ARCHIVES

Drug Development Gets Extra $500,000

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978